artificial organs; bioreactors; cellular biophysics; encapsulation; fluidised beds; haemodynamics; liver; patient monitoring; Prismaflex monitor; acute-on-chronic liver failure; alginate-encapsulated hepatocyte spheroids; bioartificial liver device development; bioartificial liver device validation; commercial medical device; complex extracorporeal circulation; fluidized bed bioreactors; hemodynamics considerations; intensive care units; liver support devices; nonadhesive coating; patient safety; petri dish; time 4 d; viable spheroids; Animals; Bioreactors; Blood; Liver; Monitoring; Plasmas; Production;
机译:基于微囊化原代猪肝细胞的流化床生物人工肝辅助装置(BLAD)具有猪内源性逆转录病毒传播的风险。
机译:基于微囊化原代猪肝细胞的流化床生物人工肝辅助装置(BLAD)具有猪内源性逆转录病毒传播的风险
机译:基于微囊化原代猪肝细胞的流化床生物人工肝辅助装置(BLAD)具有猪内源性逆转录病毒传播的风险
机译:流化床生物反应器的发展与验证宿主藻酸盐包封的肝细胞球体的流化床生物反应器
机译:通过球化和流化床工艺开发乙基纤维素包衣开发布洛芬控释
机译:基于微囊化原代猪肝细胞的流化床生物人工肝辅助装置(BLAD)具有猪内源性逆转录病毒传播的风险
机译:基于微囊化原代猪肝细胞的流化床生物人工肝辅助装置(BLAD)具有猪内源性逆转录病毒传播的风险